Congenica Launches New Host Genetics Module to Advance COVID-19 Research

/in

Link to Full Article Cambridge, United Kingdom – 22 September 2020 – Congenica has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an individual’s genomic variation and COVID-19 susceptibility, severity, and clinical outcomes. Since the beginning of the COVID-19 global pandemic outbreak, the global research community has united in an unprecedented effort […]

Read more

FundamentalVR announces appointment of Allan May, a renowned medtech pioneer, as company chairman

/in

Link to Full Article Silicon Valley heavy hitter brings decades of experience founding and growing over 70 Medtech companies to FundamentalVR to continue scaling its immersive surgical simulation platform. LONDON – September 22, 2020 – FundamentalVR, global leaders in using immersive technology to improve the way surgeons are trained, announces Allan May as Chairman of the […]

Read more

Destiny Pharma Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical infections

/in

Link to Full Article Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical infections Recruitment on track to complete year-end and report results in early 2021 Brighton, United Kingdom – 17 September 2020 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development of […]

Read more

Destiny Pharma and SporeGen® announce collaboration and Innovate UK grant award to co-develop novel, preventative treatment for COVID-19

/in

Link to Full Article Destiny Pharma and SporeGen® announce collaboration and Innovate UK grant award to co-develop novel, preventative treatment for COVID-19 SPOR-COV™ prophylactic approach targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment Innovate UK grant of £800,000 to support SPOR-COV™ programme over the next 18 months […]

Read more

New industry Advisory Group Chairs appointed AusBiotech

/in

Link to Full Article AusBiotech welcomes its new industry Advisory Group Chairs: Dr Megan Robertson, St Vincent’s Hospital Melbourne, Chair of the AusBiotech Clinical Trials Adivsory Group; and Dr Amanda Gillon, Bioscience Managers, Chair of the AusBiotech Investor Advisory Group. AusBiotech’s national advisory groups and state branch committees are important mechanisms to highlight and address […]

Read more